MSB 7.69% $1.19 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-364

  1. 363 Posts.
    lightbulb Created with Sketch. 172
    Where or what was this report part of.
    Just trying to find context.
    Cheers.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.